Literature DB >> 24039113

Clinical and neurocognitive characterization of a family with a novel MED12 gene frameshift mutation.

Gaetan Lesca1, Marie-Pierre Moizard, Gerald Bussy, Dominique Boggio, Hao Hu, Stefan A Haas, Hans-Hilger Ropers, Vera M Kalscheuer, Vincent Des Portes, Audrey Labalme, Damien Sanlaville, Patrick Edery, Martine Raynaud, James Lespinasse.   

Abstract

FG syndrome, Lujan syndrome, and Ohdo syndrome, the Maat-Kievit-Brunner type, have been described as distinct syndromes with overlapping non-specific features and different missense mutations of the MED12 gene have been reported in all of them. We report a family including 10 males and 1 female affected with profound non-specific intellectual disability (ID) which was linked to a 30-cM region extending from Xp11.21 (ALAS2) to Xq22.3 (COL4A5). Parallel sequencing of all X-chromosome exons identified a frameshift mutation (c.5898dupC) of MED12. Mutated mRNA was not affected by non-sense mediated RNA decay and induced an additional abnormal isoform due to activation of cryptic splice-sites in exon 41. Dysmorphic features common to most affected males were long narrow face, high forehead, flat malar area, high nasal bridge, and short philtrum. Language was absent or very limited. Most patients had a friendly personality. Cognitive impairment, varying from borderline to profound ID was similarly observed in seven heterozygous females. There was no correlation between cognitive function and X-chromosome inactivation profiles in blood cells. The severe degree of ID in male patients, as well as variable cognitive impairment in heterozygous females suggests that the duplication observed in the present family may have a more severe effect on MED12 function than missense mutations. In a cognitively impaired male from this family, who also presented with tall stature and dysmorphism and did not have the MED12 mutation, a 600-kb duplication at 17p13.3 including the YWHAE gene, was found in a mosaic state.
© 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  17p13.3; MED12; X-linked; YWHAE; intellectual deficiency

Mesh:

Substances:

Year:  2013        PMID: 24039113     DOI: 10.1002/ajmg.a.36162

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  13 in total

Review 1.  MED12 related disorders.

Authors:  John M Graham; Charles E Schwartz
Journal:  Am J Med Genet A       Date:  2013-10-10       Impact factor: 2.802

2.  Redefining the MED13L syndrome.

Authors:  Abidemi Adegbola; Luciana Musante; Bert Callewaert; Patricia Maciel; Hao Hu; Bertrand Isidor; Sylvie Picker-Minh; Cedric Le Caignec; Barbara Delle Chiaie; Olivier Vanakker; Björn Menten; Annelies Dheedene; Nele Bockaert; Filip Roelens; Karin Decaestecker; João Silva; Gabriela Soares; Fátima Lopes; Hossein Najmabadi; Kimia Kahrizi; Gerald F Cox; Steven P Angus; John F Staropoli; Ute Fischer; Vanessa Suckow; Oliver Bartsch; Andrew Chess; Hans-Hilger Ropers; Thomas F Wienker; Christoph Hübner; Angela M Kaindl; Vera M Kalscheuer
Journal:  Eur J Hum Genet       Date:  2015-03-11       Impact factor: 4.246

3.  Clinical Variability in Familial X-Linked Ohdo Syndrome-Maat-Kievit-Brunner Type with MED12 Mutation.

Authors:  Siddaramappa J Patil; Puneeth H Somashekar; Anju Shukla; Satish Siddaiah; Venkatraman Bhat; Katta M Girisha; Pooja N Rao
Journal:  J Pediatr Genet       Date:  2017-04-24

4.  Glial-Specific Deletion of Med12 Results in Rapid Hearing Loss via Degradation of the Stria Vascularis.

Authors:  Teng-Wei Huang; Amrita A Iyer; Jeanne M Manalo; Junsung Woo; Navish A Bosquez Huerta; Melissa M McGovern; Heinrich Schrewe; Fredrick A Pereira; Andrew K Groves; Kevin K Ohlemiller; Benjamin Deneen
Journal:  J Neurosci       Date:  2021-07-12       Impact factor: 6.167

Review 5.  MED12-Related (Neuro)Developmental Disorders: A Question of Causality.

Authors:  Stijn van de Plassche; Arjan Pm de Brouwer
Journal:  Genes (Basel)       Date:  2021-04-28       Impact factor: 4.096

6.  Nonsyndromic X-linked intellectual deficiency in three brothers with a novel MED12 missense mutation [c.5922G>T (p.Glu1974His)].

Authors:  Habib Bouazzi; Gaetan Lesca; Carlos Trujillo; Mohammad Khalid Alwasiyah; Arnold Munnich
Journal:  Clin Case Rep       Date:  2015-05-26

7.  A novel MED12 mutation associated with non-specific X-linked intellectual disability.

Authors:  Toshiyuki Yamamoto; Keiko Shimojima
Journal:  Hum Genome Var       Date:  2015-06-18

8.  Dysregulations of sonic hedgehog signaling in MED12-related X-linked intellectual disability disorders.

Authors:  Siddharth Srivastava; Tejasvi Niranjan; Melanie M May; Patrick Tarpey; William Allen; Anna Hackett; Pierre-Simon Jouk; Lucy Raymond; Slyvain Briault; Cindy Skinner; Annick Toutain; Jozef Gecz; William Heath; Roger E Stevenson; Charles E Schwartz; Tao Wang
Journal:  Mol Genet Genomic Med       Date:  2019-02-06       Impact factor: 2.183

9.  The contribution of X-linked coding variation to severe developmental disorders.

Authors:  Hilary C Martin; Eugene J Gardner; Kaitlin E Samocha; Joanna Kaplanis; Nadia Akawi; Alejandro Sifrim; Ruth Y Eberhardt; Ana Lisa Taylor Tavares; Matthew D C Neville; Mari E K Niemi; Giuseppe Gallone; Jeremy McRae; Caroline F Wright; David R FitzPatrick; Helen V Firth; Matthew E Hurles
Journal:  Nat Commun       Date:  2021-01-27       Impact factor: 14.919

10.  X-exome sequencing of 405 unresolved families identifies seven novel intellectual disability genes.

Authors:  H Hu; S A Haas; J Chelly; H Van Esch; M Raynaud; A P M de Brouwer; S Weinert; G Froyen; S G M Frints; F Laumonnier; T Zemojtel; M I Love; H Richard; A-K Emde; M Bienek; C Jensen; M Hambrock; U Fischer; C Langnick; M Feldkamp; W Wissink-Lindhout; N Lebrun; L Castelnau; J Rucci; R Montjean; O Dorseuil; P Billuart; T Stuhlmann; M Shaw; M A Corbett; A Gardner; S Willis-Owen; C Tan; K L Friend; S Belet; K E P van Roozendaal; M Jimenez-Pocquet; M-P Moizard; N Ronce; R Sun; S O'Keeffe; R Chenna; A van Bömmel; J Göke; A Hackett; M Field; L Christie; J Boyle; E Haan; J Nelson; G Turner; G Baynam; G Gillessen-Kaesbach; U Müller; D Steinberger; B Budny; M Badura-Stronka; A Latos-Bieleńska; L B Ousager; P Wieacker; G Rodríguez Criado; M-L Bondeson; G Annerén; A Dufke; M Cohen; L Van Maldergem; C Vincent-Delorme; B Echenne; B Simon-Bouy; T Kleefstra; M Willemsen; J-P Fryns; K Devriendt; R Ullmann; M Vingron; K Wrogemann; T F Wienker; A Tzschach; H van Bokhoven; J Gecz; T J Jentsch; W Chen; H-H Ropers; V M Kalscheuer
Journal:  Mol Psychiatry       Date:  2015-02-03       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.